Further, ablation of myeloid cell-specific PD-1 in a tumor model resulted in reduced tumor accumulation of myeloid-derived suppressor cells and increased T effector memory cell function enhancing overall antitumor protection (Strauss et al., 2020). The gene discussed is PDCD1; the disease is neoplasm.